<DOC>
	<DOCNO>NCT01106794</DOCNO>
	<brief_summary>The purpose study prospectively collect specimen pediatric patient diffuse intrinsic pontine glioma brainstem glioma , either therapy autopsy , order characterize molecular abnormality tumor .</brief_summary>
	<brief_title>Molecular Analysis Samples From Patients With Diffuse Intrinsic Pontine Glioma Brainstem Glioma</brief_title>
	<detailed_description>High grade diffuse intrinsic pontine glioma ( DIPG ) account approximately 80 % pediatric brainstem tumor 10 % pediatric brain tumor , lethal form brainstem gliomas child . There currently effective therapy treat tumor . We hypothesize tumor exhibit unique molecular abnormality lead altered RNA protein expression . The aim trial collect specimens pediatric patient diffuse intrinsic pontine glioma include serum , cerebrospinal fluid , urine , brain tumor constitutional tissue , therapy and/or autopsy . Our goal study tissue characterize genetic abnormality lead tumor formation order identify key molecule biomarkers target design test new effective treatment .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>Patients age clinical radiologic diagnosis diffuse intrinsic pontine glioma Patients highgrade gliomas originate brainstem Patients focal glioma ( WHO grade I/II ) brainstem Patients type infiltrative low grade ( WHO grade I II ) high grade glioma ( WHO grade III IV ) originate outside brainstem Patients harbor primary brainstem tumor histologic diagnosis ( e.g. , PNET )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>diffuse intrinsic pontine glioma</keyword>
	<keyword>DIPG</keyword>
	<keyword>childhood brainstem glioma</keyword>
	<keyword>pediatric brainstem glioma</keyword>
	<keyword>brainstem glioma</keyword>
	<keyword>BSG</keyword>
</DOC>